Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
11 October 2019 | Story Eugene Seegers | Photo Eugene Seegers
Tutu-Jonker Prestige lecture
Ingrid Mostert and Nathlene van Wyk, both from the Office of the Dean of the Faculty of Theology and Religion, with guest speaker, Prof Nico Koopman (SU), and the Dean of Theology and Religion, Prof Rantoa Letšosa.

The “rich Christian logic of Luther tells us this: ‘Forgiveness is the first word.’ It invites, facilitates, anticipates, and comes to fruition in contrition.” With these words, Prof Nico Koopman, Vice-Rector: Social Impact, Transformation, and Personnel at Stellenbosch University (SU) sought to reach the hearts of those who attended the UFS Faculty of Theology and Religion’s annual Tutu-Jonker Prestige Lecture on 19 September 2019. 

Prof Koopman’s chosen theme was No Future without Justice: The Forgiveness-Logic of Desmond Tutu and Willie Jonker, which focused on these ‘prophets of forgiveness’ as well as the praise and critique they received as a result of their actions.

On Forgiveness

Delving into the history of the relationship between these two prominent theologians, Prof Koopman first revisited the emotional scene when, in 1990, Prof Willie Jonker pleaded for forgiveness on behalf of the Dutch Reformed Church and the Afrikaner nation at an ecumenical conference in Rustenburg, describing it as personal, yet representative. This confession spoke of justice versus injustice, saying that injustice is a stumbling block to reconciliation. Later, Prof Jonker would be criticised for making this confession ‘on behalf of’ the church and white Afrikaans-speaking South Africans, yet even some of his former critics and others defended his actions. Jonker also maintained that a confession of guilt, of sin or wrongdoing, was necessary to enable reconciliation and forgiveness; action was needed to overcome these stumbling blocks. According to Prof Koopman, Prof Jonker’s logic of reconciliation follows that of the apostle Paul, in which justice is essential to the at-one-ment or atonement, reconciliation.

Next, Prof Koopman reviewed Archbishop Tutu’s unequivocal, representative, and vicarious forgiveness, for which he, too, was criticised. Prof Koopman equated this forgiveness with Lutherian tradition, as mentioned at the outset. This belief is grounded in the scriptural principle found in the Lord’s Prayer in Matthew 6:12: To forgive others, just as we have been forgiven. Prof Koopman said this amounted to passing on and sharing our forgiveness as received from God to those who have sinned against us in some way.  

Drawing from the Christian parable of the Prodigal Son in Luke 15:11-32, Prof Koopman said the road is paved for real restitution, forgiveness is available. In the parable, the father of the prodigal son ran to him and greeted him even before he could make his confession: “In the space of the hospitality of forgiveness, justice flourishes,” said Prof Koopman. “Tutu granted forgiveness with justice in mind.”

 On Justice

Justice is known as Summum Bonum, or ‘Highest Good’. Archbishop Emeritus Tutu’s message is still: ‘Seek justice’. According to Romans 14:17 and Isaiah 65:17-25, future blessings in God’s kingdom, such as peace and joy, flow from justice.

Referring to the South African Constitution, Prof Koopman said dignity is a foundational value. Recalling the 2015 #FeesMustFall protests, he said this highlighted how essential it is for dignity to be linked with justice in practice.

 Concretely seeking justice

Prof Koopman mentioned several areas in which one could ‘seek justice’ now, everywhere, and concretely ‘next door’, saying: “Human rights need right humans.”

“Firstly, break rape culture as a quest for justice NOW!” Prof Koopman described rape as oppression, cruelty, barbarism, ‘thingification,’ and dehumanisation; a violation of the most precious, cherished gift — a fellow human being.
 
Second, he said, is to oppose racism and racial determinism, especially in the field of research. Third, seeking socioeconomic liberation and fulfilling socioeconomic rights, such as access to healthcare, housing, and education.

Lastly, seeking wise hospitality and association with other races, nationalities, and cultures. Following the Tutu-Jonker Logic involves advancing justice as embracing, not alienating. 

 Porcupine Journey (‘Ystervarkpad’)

In conclusion, Prof Koopman related how porcupines need to huddle close together to conserve their body heat during cold winter nights. However, every time they get close to another porcupine, their quills prick each other, causing them to pull away. Yet, their survival depends on their overcoming those small injuries in order to benefit from each other’s body heat. 

He compared this to the situation in South Africa: There are old and new sores that require continuous confessing and offering of forgiveness. He concluded: “Embracing justice means drawing closer together to survive and thrive. Don’t seek to be right all the time; what is most important is to be forgiven. This makes our joint quests for justice sustainable.”

News Archive

Nuclear Medicine on the forefront of cancer research
2017-07-10

Description: Nuclear Medicine on the forefront of cancer research Tags: Nuclear Medicine, cancer research, Dr Je’nine Horn-Lodewyk’s, tumour detection method, cancer, Department of Nuclear Medicine 

Dr Je’nine Horn-Lodewyk’s tumour detection method
could be the cost-effective breakthrough needed to decrease
the mortality rate in breast cancer patients.
Photo: Anja Aucamp

The field of Nuclear Medicine in South Africa and the rest of the world are expanding rapidly due to the development of hybrid cameras and new radiopharmaceuticals. These developments have a huge impact on the diagnosis and therapy of cancer.

The most advanced of these cameras, Positron emission tomography combined with normal CTs (PETCT), are not yet widely available in South Africa due to the cost of the cameras and the radiopharmaceuticals. A more cost-effective alternative can be of great benefit. To achieve this, the focus should be on developing new radiopharmaceuticals that can be used with the current cost-effective gamma cameras, according to University of the Free State researcher, Dr Je’nine Horn-Lodewyk from the Department of Nuclear Medicine.

Fluorodeoxyglucose (18F-FDG), a radiolabelled glucose analogue, is currently the radiopharmaceutical most commonly used in PET/CT imaging for mainly oncology indications. Although it is considered the gold standard for imaging in several malignancies, it does have certain disadvantages. An 18F-FDG PET/CT diagnostic imaging study can cost between R25 000 and R35 000 for a single patient in the private sector. The 18F-FDG is also more radioactive, which requires much stricter handling and shielding to avoid high radiation dosages to staff and patients.

Successful research potential innovative solution
In the search for the ideal radiopharmaceutical for tumour detection, the South African National Nuclear Energy Corporation (Necsa) developed a local synthesis process for ethylenedicysteine-deoxyglucose (EC-DG). EC-DG is also a glucose analogue similar to FDG. They succeeded in labelling the compound with Technetium-99-metastable-pertechnetate (99mTcO4-), the most common nuclear medicine isotope used for approximately 95% of nuclear medicine procedures, creating 99mTc-EC-DG.

In partnership with Dr Horn-Lodewyk, this compound was successfully used in various animal models and clinical scenarios, resulting in approval by the Medicine Control Council to use it in a human study. Research is also planned in order to investigate diagnostic accuracy in other cancers like lymphoma.  The end result of this research can produce a radiopharmaceutical that is cost effective, does not require the use of costly specialised equipment, has no significant side-effects, no special patient preparation, renders late imaging possible, and has decreased radiation risks.

Dr Horn-Lodewyk is grateful for the support of her mentor, Prof Anton Otto, as well as Dr Gert Engelbrecht, Head of the Department of Nuclear Medicine, Prof Jan Rijn Zeevaart from North-West University’s Preclinical Drug Development Platform and Necsa, and Judith Wagener from Necsa. This innovative research would also not have been possible without the financial assistance of Dr Glen Taylor and Eleanor van der Westhuizen in the Directorate of Research Development.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept